======= GPR37L1 ======= == Gene Information == * **Official Symbol**: GPR37L1 * **Official Name**: G protein-coupled receptor 37 like 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9283|9283]] * **UniProt**: [[https://www.uniprot.org/uniprot/O60883|O60883]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GPR37L1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GPR37L1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617630|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Receptor for the neuroprotective and glioprotective factor prosaposin. Ligand binding induces endocytosis, followed by an ERK phosphorylation cascade. {ECO:0000269|PubMed:23690594}. |7tm 1| |prosaposin receptor activity| |positive regulation of cerebellar granule cell precursor proliferation| |regulation of cerebellar granule cell precursor proliferation| |negative regulation of astrocyte differentiation| |negative regulation of hydrogen peroxide-induced cell death| |negative regulation of response to reactive oxygen species| |negative regulation of systemic arterial blood pressure| |negative regulation of cellular response to drug| |regulation of hydrogen peroxide-induced cell death| |negative regulation of glial cell differentiation| |regulation of astrocyte differentiation| |negative regulation of response to drug| |negative regulation of smoothened signaling pathway| |regulation of response to reactive oxygen species| |regulation of cellular response to drug| |G protein-coupled peptide receptor activity| |negative regulation of gliogenesis| |negative regulation of blood pressure| |negative regulation of oxidative stress-induced cell death| |negative regulation of cellular response to oxidative stress| |negative regulation of response to oxidative stress| |peptide binding| |positive regulation of neural precursor cell proliferation| |ciliary membrane| |regulation of oxidative stress-induced cell death| |regulation of glial cell differentiation| |regulation of cellular response to oxidative stress| |regulation of smoothened signaling pathway| |adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway| |regulation of response to oxidative stress| |regulation of neural precursor cell proliferation| |regulation of systemic arterial blood pressure| |regulation of response to drug| |regulation of gliogenesis| |regulation of blood pressure| |receptor complex| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |negative regulation of neuron differentiation| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |negative regulation of neurogenesis| |negative regulation of nervous system development| |negative regulation of cell development| |blood circulation| |circulatory system process| |positive regulation of nervous system development| |positive regulation of MAPK cascade| |regulation of neuron differentiation| |negative regulation of cell differentiation| |G protein-coupled receptor activity| |regulation of cellular response to stress| |regulation of MAPK cascade| |regulation of neurogenesis| |positive regulation of cell population proliferation| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |negative regulation of cell death| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |negative regulation of multicellular organismal process| |positive regulation of protein modification process| |negative regulation of signal transduction| |G protein-coupled receptor signaling pathway| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |regulation of protein phosphorylation| |regulation of response to stress| |generation of neurons| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |neurogenesis| |positive regulation of signal transduction| |regulation of cell death| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp132|Metformin 40μM R03 exp132]]|-1.74| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12161 * **Expression level (log2 read counts)**: 2.09 {{:chemogenomics:nalm6 dist.png?nolink |}}